-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $564K.
- Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2018 was $0.000.
- Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2017 was $0.000.
Current Income Tax Expense (Benefit), Annual (USD)